- CANOC Scholarship
- CANOC Community Investigator Program
- Scholar and Community
The CANOC SCHOLARSHIP Awards Program
The Canadian HIV Observational Cohort (CANOC) Collaborative Research Centre is pleased to announce a joint scholarship program with the Canadian Institutes of Health Research (CIHR) Canadian HIV Trials Network (CTN). This team approach to training and knowledge translation creates unique opportunities for advanced multi-site and multi-investigator training. 2017-2018 scholarship funds will be available to Master’s, PhD, and Post-Doctoral students.
Launch Date: February 15th, 2017
Application Deadline: April 1st, 2017
Start date: September 1st, 2017
Canadian HIV Observational Cohort (CANOC) Collaborative Research Centre
CANOC is Canada’s first integrated network of HIV treatment information from eleven cohort databases across British Columbia, Saskatchewan, Ontario, Quebec, and Newfoundland. This collaboration gives researchers the opportunity to conduct large scale and detailed analyses of treatment outcomes and to assess variations across regions and provinces.
The CIHR Canadian HIV Trials Network (CTN)
The CTN is a nationally funded partnership committed to developing treatments, vaccines and a cure for HIV diseases and related conditions through scientifically rigorous and ethical research.
The CANOC Scholarship Awards Program offers training opportunities to outstanding young researchers at major Canadian academic institutions. The goals of the program are:
- To help meet the need for trained investigators of HIV projects in Canada;
- To foster a dynamic research environment at Canadian HIV care centres and institutions;
- To promote health services and cost-effectiveness research related to HIV/AIDS care.
Scholarships are awarded at the beginning of each academic year. Scholarships are provided on behalf of the CANOC Centre.
Each awardee receives funding based on the degree being sought: Master’s –$17,500; PhD—$21,500; or Postdoctoral—$55,000. An additional travel allowance of up to $2,500 may be available for travel costs.
If a scholarship is not held for the full year, the scholar must immediately notify the CIHR Canadian HIV Trials Network. A prorated reduction in funds will then be made.
Applicants must be accepted to or currently enrolled in a full time graduate level academic program at a recognized Canadian university. Applicants must be a Canadian citizen or have landed immigrant status. International students studying in or outside of Canada will not be considered. Canadian students currently living outside of Canada may be considered depending on their ability to demonstrate a sufficient connection to both the supervisor and the Canadian university where they are enrolled. Current CANOC Co-investigators are not eligible for this scholarship.
Note: MDs may qualify for the Post-Doctoral award. MPH students are eligible for the Master’s scholarship given an interest in pursuing a career in research, which should be explicitly stated in the application.
The supervisor must be an affiliate investigator of the CANOC Centre, and be willing to direct the scholar in an experiential learning program. A list of all potential CANOC supervisors can be found at: www.canoc.ca/about-us/principal-investigators/
Each scholar must develop and run their research work at a recognized Canadian institution. The sponsoring institution must be prepared to provide suitable space and research facilities.
If a scholar transfers to another institution, the award terminates. However, the scholar may apply to have the unspent portion allocated for use at the new institution. Such a request must be supported by a revised application plus a letter of undertaking from the supervisor at the new institution in Canada, similar in content to the letter required from the supervisor in the initial application.
The application should describe a yearly training program. All awards are approved on a year-by-year basis, with a starting date of September 1st. Alternate starting dates may be considered upon request. The maximum tenure for an awardee is two years. To be considered for the second year, the scholar must submit a progress report after the first seven months, as outlined in the section entitled “Request for Renewal.”
Research Project Protocol
During the course of the scholarship, each scholar is required to develop a research protocol and submit it to a supervisor for support. The research project must make use of the CANOC data that addresses one of CANOC’s key research themes.
Earnings from Other Sources
During the tenure of this award the scholar must devote the majority of their research time to the CANOC project. The recipient may earn additional awards and remuneration at the discretion of the sponsoring institution.
The award is paid to the scholar’s sponsoring institution in a lump sum installment. The institution in turn, pays the scholar in accordance with its payroll procedures, making the appropriate deductions. The institution will apply policies regarding medical benefits, vacation, leave of absence, etc. according to their internal processes.
At the end of the scholarship period, the scholar must provide a written report detailing their achievement of training objectives as listed in the application. This will include presentations, publications, the yearly presentation at CAHR, as well as indication of future plans. The report should include a list of the projects that the scholar was involved with and any publications and/or presentations that resulted.
Scholars are required to acknowledge the assistance given by CANOC and the CTN, the sponsors of the award, in any publications or presentations.
The training program contemplated by the applicant and supervisor should supplement the applicant’s present training and experience in the specialized field of HIV/AIDS.
A complete application must contain:
- A cover letter from the applicant, which must include (max: 2 pages):
- A summary of training and experience to-date (particularly as they pertain to HIV);
- A description of the applicant’s current research activities and future plans;
- How the scholarship fits into the applicant’s long-term career plans;
- How CANOC will play a role in the applicant’s research, including plans to use the CANOC dataset to address at least one of CANOC’s key research themes.
- A letter of undertaking from the supervisor, which must include (max: 2 pages):
- The nature and content of the research project arranged for the candidate;
- Relevant training activities, formal and informal, to be provided by the supervisor;
- How the proposed training program would supplement the candidate’s present training;
- A description of the supervisor’s recent and current research projects, as they relate to the candidate’s career plans;
- Additional information about the supervisor’s current position and background, including relevant supervisory experience and publications;
- Information regarding additional remuneration of the scholar.
- A completed, signed application form.
- Letters from at least two references assessing the applicant’s qualifications as a scholarship candidate.
- Any other documents the applicant feels are pertinent to the application.
Request for Renewal
To be approved for the second year, the scholar must submit a progress report at the end of the first seven months. It must include:
- A description of progress to-date in the training program outlined in the initial application;
- A description of any progress made towards the development of a research protocol;
- A detailed outline of the proposed activities during year two;
- A performance assessment from their supervisor;
- A statement regarding additional remuneration received by the scholar during the first year of the award;
- Any other supporting documents thought to be pertinent.
THE DEADLINE FOR SUBMITTING APPLICATIONS IS APRIL 1st, 2017.
Complete applications and requests for renewal must contain all the required information as listed in the previous section. These should be submitted electronically to:
Karyn Gabler, CANOC Research Coordinator
Epidemiology & Population Health
BC Centre for Excellence in HIV/AIDS
1026 Nelson Street, Vancouver BC, V6E 4S7
Email: email@example.com Tel: 604-558-6685
Late or incomplete applications cannot be considered.
More information may be obtained by sending an email to the CANOC coordinator at firstname.lastname@example.org or Ms. Jacqueline Sas (email@example.com) at the CTN’s National Centre.
The Adjudication Committee operates under the policies of the CTN and CIHR. Its members serve without remuneration. Composed chiefly of distinguished clinical researchers, the Adjudication Committee relies heavily on the peer review process. The adjudication process favours applicants with high potential who are working with an affiliate investigator of CANOC that can channel their potential into broad experience in the formulation and execution of research projects, including: scientific methodology, epidemiology and data management.
All factors are considered, including:
- The applicant’s ability, educational background, and career plans;
- The proposed program of training and supervision to be provided;
- The research activities to be undertaken.
According to the Privacy Act and the Access to Information Act, applicants must be aware of the use and disclosure of the information contained in their application. This information will not be released without the candidate’s consent.
Announcements of Winners
The recipients of the CANOC Scholarship Awards will be announced by mail in June 2017.
CANOC Community Investigator positions for 2017-2018 have now been filled.
CANOC is excited to welcome three new Community Investigators for the September 1, 2017 – August 31, 2018 program year! Applications for the 2018-2019 program will be available in February 2018.
Canadian HIV Observational Cohort (CANOC) Collaborative Research Centre
The Canadian HIV Observational Cohort (CANOC) Collaborative Research Centre examines the impact of HIV health services and treatment programs on the health and wellbeing of persons living with HIV across Canada. This is Canada’s largest multi-province research initiative to examine the effectiveness of antiretroviral therapy (ART) across Canadian populations.
The CANOC database allows for the analysis of non-identifying information collected from study participants who are receiving ART at locations in British Columbia, Saskatchewan, Ontario, Quebec, and Newfoundland. The purpose of the study is to answer questions that will better inform HIV policy and delivery of care in Canada. Please visit www.canoc.ca for more information.
The Community Investigator Program
CANOC Community Investigators will meet with a CANOC Principal Investigator throughout the year, participate in the CANOC Knowledge Translation and Mentorship Working Group and Steering Committee teleconferences, and complete a CANOC research project. The Community Investigator will work with their supervisor (a CANOC Principle Investigator), to define the research project. This may involve developing a new research question, contributing to an existing research project, or engaging in knowledge translation activities to share research findings within their community. To further support this reciprocal learning and knowledge exchange process, a participating CANOC Scholar of that academic year, or other graduate-level student, will act as a resource to the matched Community Investigator. Community Investigators will be supported in identifying a research partner with corresponding research interests and learning goals.
The CANOC Centre will compensate the Community Investigators for their time, and financial support will be provided to prepare for and attend meetings. This includes attendance at up to one national conference (pending approval from the CANOC management team). The Community Investigator will be expected to commit approximately 200 hours throughout their tenure, during which they will be compensated a total of $5000 plus travel expenses.
The appointment is for one year, from September 1, 2017 to August 31, 2018, with possibility of renewal.
Before applying, interested individuals should attempt to seek support from one of the CANOC Centre Principal Investigators. A list of these investigators is provided at the end of this page. If the applicant is unable to connect with a CANOC Principal Investigator before the application deadline, they may suggest the name of a Principal Investigator with whom they are interested in working. In this latter scenario, the individual will be assigned a supervisor after the application deadline.
Expectations during Community Investigator tenure
1. Research project development and completion:
- Design a research question, project or knowledge exchange project with the support of their research team
- Aspects of the project design may involve a composition of the following: development of a data request form, abstract and manuscript writing, contributions to a non-scientific journal or blog, the preparation of community-based workshops, oral or poster presentations at conferences, and the broader promotion of research findings and approaches
2. Knowledge translation activities:
- Advise on and help build community partnerships
- Assist with the sharing of information, by participating in the CANOC Knowledge Translation and Mentorship Working Group and Steering Committee teleconferences, and and other relevant meetings and workshops
CANOC aims to conduct research that is relevant to and reflective of Canada’s diverse HIV-positive population and therefore seeks applications from individuals with different backgrounds, including those who are living with HIV, and/or identify with key affected populations (such as persons of Indigenous ancestry, people who inject drugs, transgender individuals, and men who have sex with men).
Prospective applicants should have:
- Basic knowledge and understanding of HIV and current treatments
- An awareness of the issues important to people living with HIV in Canada
- An interest in developing research skills and approaches in community-based research
For any questions regarding the CANOC Community Investigator Program, please contact study coordinator Karyn Gabler (firstname.lastname@example.org), who will forward queries as necessary.
*CANOC Co-Principal Investigators
Robert Hogg, PhD (Nominated Principal Applicant) is a Professor in the Faculty of Health Sciences at Simon Fraser University and Director of the Epidemiology and Population Health Program at the BC Centre for Excellence in HIV/AIDS.
Mark Hull, MD is a Clinical Assistant Professor in the Department of Medicine at the University of British Columbia, a Research Scientist at the BC Centre for Excellence in HIV/AIDS, and an Attending Medical Physician at St. Paul’s Hospital.
Julio Montaner, MD, DSc (Hon.) is the Chair in AIDS Research and Head of the Division of AIDS in the Faculty of Medicine at the University of British Columbia, Director of the BC Centre for Excellence in HIV/AIDS, and the past-president of the International AIDS Society.
Bohdan Nosyk, PhD is a Health Economist at the BC Centre for Excellence in HIV/AIDS, an Associate Professor and St. Paul’s Hospital Canfar Chair in HIV/AIDS Research in the Faculty of Health Sciences at Simon Fraser University, and an Adjunct Scientist at the UCLA Integrated Substance Abuse Programs.
Deborah Kelly, PharmD is an Associate Professor and clinical pharmacotherapy specialist at the Memorial University of Newfoundland.
Tony Antoniou, PharmD, PhD is a Scientist in the Li Ka Shing Knowledge Institute and Department of Family and Community Medicine at St. Michael’s Hospital, and an Adjunct Scientist at the Institute for Clinical Evaluative Sciences (ICES).
Ahmed Bayoumi, MD, MSc is a Research Scientist at the Centre for Research on Inner City Health at St. Michael’s Hospital, an Associate Professor in the Department of Medicine at the University of Toronto, and Scientist in the Keenan Research Centre of the Li Ka Shing Knowledge Institute. He is also a practicing clinician and Adjunct Scientist at ICES.
Ann Burchell, PhD is an Epidemiologist and Scientist with the Department of Family and Community Medicine and Li Ka Shing Knowledge Institute at St. Michael’s Hospital, Toronto. She holds a degree in epidemiology from the University of Toronto (MSc) and McGill University (PhD) and has academic appointments as Assistant Professor, Dalla Lana School of Public Health, University of Toronto; Adjunct Professor, Division of Cancer Epidemiology, McGill University; and Adjunct Scientist, Institute for Clinical Evaluative Medicine, Toronto.
Curtis Cooper, MD, MSc is an Associate Professor at the University of Ottawa, Infectious Diseases Consultant with the Ottawa Hospital, and Associate Clinical Researcher with the Ottawa Health Research Institute, focusing on hepatitis C co-infection and liver disease.
Mona Loutfy, MD, MPH is an Associate Professor in the Department of Medicine at the University of Toronto, a Clinician Scientist at Women’s College Hospital, has an HIV practice at Maple Leaf Medical Clinic, and is an ICES-affiliated scientist.
Janet Raboud, PhD is a Professor in the Division of Biostatistics, Dalla Lana School of Public Health, University of Toronto, a Scientist in the Toronto General Research Institute at the University Health Network, an ICES-affiliated scientist, and holds the OHTN Chair in Biostatistics.
Sean Rourke, PhD, FCAHS is the Scientific and Executive Director of the Ontario HIV Treatment Network (OHTN), Professor of Psychiatry at the University of Toronto, and Clinical Neuropsychologist and Scientist at St. Michael’s Hospital.
Marina Klein, MD, MSc is an Associate Professor in the Department of Medicine, Division of Infectious Diseases and Immunodeficiency Services at the McGill University Health Centre in Montreal.
Réjean Thomas, MD, CM, OQ, DHC is the Founder, Chairman and CEO of Clinque médicale l’Actuel, family physician at l’Actuel, and medical advisor at Centre hospitalier de l’Université de Montréal (CHUM).
Christos Tsoukas, MD, MSc is a Professor in the Department of Medicine at McGill University. He has received the Order of Canada (1999), Louis Pasteur Award for Excellence in Clinical Medicine in the fight against HIV/AIDS (1996), and named a Fellow of the Canadian Academy of Health Sciences (2012).
Stephen Sanche, MD is an Associate Professor in the Faculty of Medicine at the University of Saskatchewan, and has active clinical practices in the fields of Infectious Disease Medicine and Medical Microbiology at the University of Saskatchewan.
Alexander Wong, MD is an Infectious Diseases physician in Regina and Clinical Director of the Saskatchewan HIV Provincial Leadership Team, where he helps provide oversight and direction for HIV programming. He has specific clinical interests in HIV and hepatitis C.
Scholar and Community Investigators
- Aranka Anema (2008-2009) was a PhD candidate at the University of British Columbia under the supervision of Dr. Julio Montaner. Her research examined the impact of food insecurity on HIV clinical outcomes among individuals receiving ART in CANOC-affiliated cohorts.
- Tony Antoniou (2008-2010) was a PhD student under the supervision of Dr. Mona Loutfy. His area of study was population-based health services research and pharmacoepidemiology in the field of HIV.
- Joseph Eibl (2015-2016) is a Post-Doctoral Fellow at Northern Ontario School of Medicine, working with Dr. David Marsh. Joseph is evaluating the impact of coordinated model of care for HIV-patients with co-occurring opioid-dependence.
- Niamh Higgins (2010-2011) was an MSc student at McGill University, working with Dr. Marina Klein. Niamh completed a research project investigating medication errors within the Description of Factors Associated with Medication Errors in an HIV Ambulatory Care Setting (DEFEAT Study).
- Kevin Johns (2010-2012) was a PhD candidate at the University of British Columbia, under the supervision of Dr. Marianne Harris. His work focused on determining the metabolic profile time course among HIV-positive individuals initiating ART in Canada.
- Lauren MacKenzie (2016-2017) has an MD from the University of Calgary and is completing an HIV Clinical Fellowship at the BC-CfE under the supervision of Dr. Mark Hull. Her research examines the impact of geographic location on outcomes within the Canadian HIV care cascade.
- Rachel McGovern (2009-2010) is a PhD student at the University of British Columbia under the supervision of Dr. Richard Harrigan. Her primary research focus is the application of genotyping methods for characterizing HIV-1 with particular interest in viral tropism, and response to CCR5 antagonists in various patient groups.
- Taylor McLinden (2015-2017) is a PhD candidate at McGill University working with Dr. Joe Cox. Taylor’s research focuses on the association of injection drug use and food insecurity in HIV-HCV co-infected individuals in Canada.
- Patricia Ndumbi (2010-2012) was a PhD student at McGill University, working with Dr. Christos Tsoukas. She studied the impact of long-term successful ART on altered T-cell homeostasis and T-cell ratio dysregulation among treated CANOC participants.
- Dr. Tyler O’Neill (2015-2017) is a PhD candidate at the University of Toronto, working with Dr. Ann Burchell. Tyler’s research focuses on gender differences in HIV-positive patients on antiretroviral therapy co-infected with Hepatitis C virus.
- Alexis Palmer (2011-2012) was a PhD student in the Faculty of Health Sciences at Simon Fraser University, working with Dr. Robert Hogg. Alexis’ primary research interest within CANOC is to evaluate late initiation of antiretroviral therapy among youth living with HIV in Canada.
- Urvi Rana (2016-2017) is an MSc student at the University of Ottawa, working with Dr. Curtis Cooper. Her research focuses on Hepatitis B characteristics and clinical outcomes in HIV co-infected individuals on antiretroviral therapy.
- Hasina Samji (2014-2015) was a PhD candidate at the John Hopkins Bloomberg School of Public Health. Her research examined social and structural barriers to the initiation and continuation of HIV treatment and the impact of each on HIV disease progression.
- Dr. Phan Sok (2010-2011) is a PhD student at the University of Toronto, working with Drs. Sean Rourke and Ann Burchell. He is examining the influence of aging on treatment outcomes within the CANOC cohort.
- Luke Swenson (2008-2009) was a PhD student at the University of British Columbia under the supervision of Dr. Richard Harrigan. His primary study area is the utility (sensitivity/specificity/negative and positive predictive values) of a weighted mutation list for predicting risk for abacavir hypersensivity (HLA-B*5701 positive).
- Betty Yazdani (2015-2016) is an MSc candidate at Simon Fraser University, working with Dr. Bodhan Nosyk. Betty’s research focuses on the distribution and determinants of hospital readmission among people living with HIV/AIDS in British Columbia.
- Man Wah Yeung (2011-2013) was an MSc student at McGill University, working with Dr. Marina Klein. Her research focuses on liver disease-related outcomes of antiretroviral therapy treatment interruptions among HCV/HIV co-infected adults in CANOC.